BioCryst Pharmaceuticals, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 05/08/2026 | Mar 2026Filed 05/08/2026 | Sep 2025Filed 04/11/2025 | Jun 2025Filed 05/08/2026 | Mar 2025Filed 05/08/2026 | Sep 2024Filed 04/11/2025 | Jun 2024Filed 04/11/2025 | Mar 2024Filed 04/11/2025 |
|---|---|---|---|---|---|---|---|---|
| $218 | $156 | $159 | $163 | $146 | $117 | $109 | $93 | |
| $78 | −$722 | $13 | $5.1 | $0 | −$14 | −$13 | −$35 | |
| $0.30 | −$2.98 | $0.06 | $0.02 | $0.00 | −$0.07 | −$0.06 | −$0.17 | |
| 265 | 242 | 220 | 220 | 215 | 207 | 206 | 206 |
Trend